These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38653501)

  • 41. N-glucuronidation of nicotine and cotinine in human: formation of cotinine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases.
    Ghosheh O; Hawes EM
    Drug Metab Dispos; 2002 Sep; 30(9):991-6. PubMed ID: 12167564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions
    Kahma H; Filppula AM; Neuvonen M; Tarkiainen EK; Tornio A; Holmberg MT; Itkonen MK; Finel M; Neuvonen PJ; Niemi M; Backman JT
    Drug Metab Dispos; 2018 Feb; 46(2):141-150. PubMed ID: 29138287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanistic Modeling to Predict Midazolam Metabolite Exposure from In Vitro Data.
    Nguyen HQ; Kimoto E; Callegari E; Obach RS
    Drug Metab Dispos; 2016 May; 44(5):781-91. PubMed ID: 26956641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of human uridine diphosphate-glucuronosyltransferase isoforms responsible for the glucuronidation of 10,11-dihydro-10-hydroxy-carbazepine.
    Huang K; Que L; Ding Y; Chu N; Qian Z; Qin W; Chen Y; Zhang J; He Q
    J Pharm Pharmacol; 2021 Mar; 73(3):388-397. PubMed ID: 33793880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regioselective glucuronidation of andrographolide and its major derivatives: metabolite identification, isozyme contribution, and species differences.
    Tian X; Liang S; Wang C; Wu B; Ge G; Deng S; Liu K; Yang L; Ma X
    AAPS J; 2015 Jan; 17(1):156-66. PubMed ID: 25204783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of a "Fit for Purpose" PBPK Model to Investigate the CYP3A4 Induction Potential of Enzalutamide.
    Narayanan R; Hoffmann M; Kumar G; Surapaneni S
    Drug Metab Lett; 2016; 10(3):172-179. PubMed ID: 27604990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imipramine N-glucuronidation in human liver microsomes: biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms.
    Nakajima M; Tanaka E; Kobayashi T; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2002 Jun; 30(6):636-42. PubMed ID: 12019188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simulation of the Pharmacokinetics of Oseltamivir and Its Active Metabolite in Normal Populations and Patients with Hepatic Cirrhosis Using Physiologically Based Pharmacokinetic Modeling.
    Chen Y; Ke M; Xu J; Lin C
    AAPS PharmSciTech; 2020 Mar; 21(3):98. PubMed ID: 32128656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucuronidation of 1'-hydroxyestragole (1'-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9.
    Iyer LV; Ho MN; Shinn WM; Bradford WW; Tanga MJ; Nath SS; Green CE
    Toxicol Sci; 2003 May; 73(1):36-43. PubMed ID: 12657745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incorporation and Performance Verification of Hepatic Portal Blood Flow Shunting in Minimal and Full PBPK Models of Liver Cirrhosis.
    Small BG; Hatley O; Jamei M; Gardner I; Johnson TN
    Clin Pharmacol Ther; 2023 Dec; 114(6):1264-1273. PubMed ID: 37620290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physiologically based pharmacokinetic modeling to predict complex drug-drug interactions: a case study of AZD2327 and its metabolite, competitive and time-dependent CYP3A inhibitors.
    Guo J; Zhou D; Li Y; Khanh BH
    Biopharm Drug Dispos; 2015 Nov; 36(8):507-19. PubMed ID: 26081137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.
    Romero-Lorca A; Novillo A; Gaibar M; Bandrés F; Fernández-Santander A
    PLoS One; 2015; 10(7):e0132269. PubMed ID: 26176234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of afloqualone N-glucuronidation: species differences and identification of human UDP-glucuronosyltransferase isoform(s).
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Jan; 33(1):60-7. PubMed ID: 15475412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictions of metabolic drug-drug interactions using physiologically based modelling: Two cytochrome P450 3A4 substrates coadministered with ketoconazole or verapamil.
    Perdaems N; Blasco H; Vinson C; Chenel M; Whalley S; Cazade F; Bouzom F
    Clin Pharmacokinet; 2010 Apr; 49(4):239-58. PubMed ID: 20214408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
    den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
    Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John's Wort.
    Adiwidjaja J; Boddy AV; McLachlan AJ
    Clin Pharmacokinet; 2019 Jul; 58(7):911-926. PubMed ID: 30675694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes.
    Fang JL; Beland FA; Doerge DR; Wiener D; Guillemette C; Marques MM; Lazarus P
    Cancer Res; 2002 Apr; 62(7):1978-86. PubMed ID: 11929814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.
    Itäaho K; Mackenzie PI; Ikushiro S; Miners JO; Finel M
    Drug Metab Dispos; 2008 Nov; 36(11):2307-15. PubMed ID: 18719240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating a physiologically based pharmacokinetic model for predicting the pharmacokinetics of midazolam in Chinese after oral administration.
    Wang HY; Chen X; Jiang J; Shi J; Hu P
    Acta Pharmacol Sin; 2016 Feb; 37(2):276-84. PubMed ID: 26592516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.